
Sign up to save your podcasts
Or


Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin.
See omnystudio.com/listener for privacy information.
By Bloomberg4.6
1616 ratings
Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin.
See omnystudio.com/listener for privacy information.

977 Listeners

406 Listeners

1,173 Listeners

2,175 Listeners

1,993 Listeners

427 Listeners

970 Listeners

797 Listeners

196 Listeners

71 Listeners

208 Listeners

1,320 Listeners

65 Listeners

30 Listeners

64 Listeners

435 Listeners

4 Listeners

58 Listeners

233 Listeners

230 Listeners

69 Listeners

87 Listeners

80 Listeners

81 Listeners

85 Listeners

403 Listeners

14 Listeners

7 Listeners

2 Listeners

119 Listeners